ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981